Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Acrux Limited ( (AU:ACR) ) has issued an update.
Acrux Limited has announced the issuance of free attaching options to acquire fully paid ordinary shares under a new prospectus, effective January 17, 2025. These options are being offered to eligible shareholders, investors, and lead managers, with conditions including shareholder approval and an exercise price set at $0.0525. This initiative aims to strengthen Acrux’s market position by leveraging strategic investments and partnerships.
More about Acrux Limited
Acrux Limited operates in the pharmaceutical sector, focusing on developing and commercializing products in the healthcare market.
YTD Price Performance: 10.0%
Average Trading Volume: 3,250
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.01M
See more data about ACR stock on TipRanks’ Stock Analysis page.